18-62716189-C-T
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_194449.4(PHLPP1):c.506C>T(p.Thr169Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00019 in 1,520,564 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. T169S) has been classified as Uncertain significance.
Frequency
Consequence
NM_194449.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
PHLPP1 | NM_194449.4 | c.506C>T | p.Thr169Ile | missense_variant | 1/17 | ENST00000262719.10 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
PHLPP1 | ENST00000262719.10 | c.506C>T | p.Thr169Ile | missense_variant | 1/17 | 1 | NM_194449.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000105 AC: 16AN: 151934Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.000113 AC: 13AN: 114750Hom.: 0 AF XY: 0.0000631 AC XY: 4AN XY: 63372
GnomAD4 exome AF: 0.000199 AC: 273AN: 1368630Hom.: 0 Cov.: 32 AF XY: 0.000184 AC XY: 124AN XY: 674798
GnomAD4 genome AF: 0.000105 AC: 16AN: 151934Hom.: 0 Cov.: 31 AF XY: 0.0000809 AC XY: 6AN XY: 74200
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 13, 2022 | The c.506C>T (p.T169I) alteration is located in exon 1 (coding exon 1) of the PHLPP1 gene. This alteration results from a C to T substitution at nucleotide position 506, causing the threonine (T) at amino acid position 169 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at